Evidence map›Paper›PMID 41257606›Full record

ArticleBMC genomics2025

Genomic evolution and stability of the mcr-1-harboring IncI2 plasmid in the presence and absence of colistin.

Cong Shen, Meina Wu, Minxuan Su, Hao Wu, Yushun Chen, Maimaitili Gulimire, Kai Lan, Chanjing Zhao, Xi Zhang, Li Luo and 9 more

Abstract read
In one paragraph

Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Cong Shen *The Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China. shencong@gzucm.edu.cn.
Meina Wu *The Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China.
Minxuan Su *The Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China.
Hao Wu *Department of Otolaryngology, Hospital of Honghe State Affiliated to Kunming Medical University, Southern Central Hospital of Yunnan Province, Mengzi, China.
Yushun ChenThe Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China.
Maimaitili GulimireThe Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China.
Kai LanThe Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China.
Chanjing ZhaoThe Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China.
Xi ZhangThe Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China.
Li LuoThe Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China.
Shuan WenThe Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China.
Hongyun ZhouClinical Laboratory, Lishui People's Hospital, Lishui, Zhejiang, China.
Jieying PuThe Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China.
Jianming ZengThe Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China.
Lingqing XuThe Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.
Zhongde ZhangThe Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China.
Bin HuangClinical Laboratory, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Yueting JiangClinical Laboratory, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. jyting8899@126.com.
Cha ChenThe Second Clinical Medical College, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Neihuanxi Road, Guangzhou, China. chencha@gzucm.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe emergence of plasmid-mediated colistin resistance, primarily driven by the mcr-1 gene, represents a major global health threat. IncI2 plasmids, one of the leading carriers of mcr-1, have been frequently recovered from clinical and agricultural settings. However, their persistence in the absence of antibiotic pressure and adaptive responses to colistin exposure remain poorly understood.

methodsWe conducted 60-day laboratory evolution experiments using Escherichia coli C600 carrying the mcr-1-harboring IncI2 plasmid pBD110 under three colistin concentrations (0, 2, and 4 mg/L). Stability was evaluated using polymerase chain reaction (PCR). Bacterial fitness was assessed using growth curve analysis and competition assays. Antimicrobial susceptibility was determined by the broth microdilution method. Conjugation potential was examined using conjugation experiments. Genomic alterations were investigated using whole-genome sequencing combined with bioinformatic analysis.

resultspBD110 was stably maintained for 120 passages under all conditions, with no significant loss observed in the absence of colistin. Under strong selection (4 mg/L), plasmid abundance increased, whereas moderate pressure (2 mg/L) led to fitness costs and reduced plasmid copy number. Whole-genome sequencing revealed distinct adaptive strategies: plasmids under non-selective conditions accumulated mutations in conjugation-related genes, enhancing transfer frequency, whereas those under colistin exposure retained structural stability but acquired shufflon inversions that impaired conjugation. Host genomes accumulated numerous chromosomal mutations, particularly in metabolic and stress response pathways, to compensate for resistance-associated burdens.

conclusionsIncI2 plasmids exhibit dual evolutionary strategies. In the absence of colistin, they optimized horizontal transfer, whereas under selective pressure, they prioritized the stability and vertical inheritance of mcr-1. These findings provide new insights into the persistence and dissemination of colistin resistance and highlight evolutionary trade-offs that shape plasmid-host coadaptation.

Indexed as

Anti-Bacterial AgentsColistinEscherichia coliEscherichia coli ProteinsEvolution, MolecularGenomic InstabilityPlasmidsConjugation, GeneticDrug Resistance, BacterialMicrobial Sensitivity TestsWhole Genome SequencingAnti-Bacterial AgentsColistinEscherichia coli ProteinsMCR-1 protein, E coliBacterial fitnessColistin resistanceExperimental evolutionIncI2 plasmidMcr-1Plasmid conjugationPlasmid stability

Identifiers

PMID41257606
PMCPMC12750680

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.